Guvacine

Guvacine

SCHEMBL336053

O=C(O)C1=CCCNC1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guvacine SCHEMBL9569008 0.98 TSHR (0.96)
Guvacine SCHEMBL1057880 0.98 BLM (1.00)
SCHEMBL9569044 0.84 TSHR (0.72)
SCHEMBL18808188 0.80
SCHEMBL9499237 0.80
SCHEMBL6215781 0.80
Hydrochloric Acid SCHEMBL5245635 0.78 BLM (0.68)
SCHEMBL17897341 0.76
SCHEMBL20314870 0.75 TSHR (0.60)
SCHEMBL9497394 0.75 TSHR (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 761 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024233640-A1 COMPOSITIONS AND METHODS FOR INHIBITING SEIZURES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-11-14 WO claimed
US-20230147467-A1 Novel Contrast Agents and Imaging Methods for Early Detection of Diseases ALGBURI ISHTAR FAISAL (CA) 2023-05-11 US claimed
WO-2022153228-A1 PURIFICATION OF PHYTOCHEMICAL(S) FROM ARECA WASH LIQUID VENKATRAMAN BHAT GANESH (IN) 2022-07-21 WO claimed
WO-2021203033-A2 METHODS AND COMPOSITIONS TO ALTER HEPATIC GABA RELEASE TO TREAT OBESITY-RELATED CONDITIONS ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2021-10-07 WO claimed
CN-113053455-A Application of potential taste-effect associated key quality attribute identification method in pediatric food retention removing and cough relieving oral liquid 北京中医药大学 2021-06-29 CN claimed
WO-2021062048-A2 METHODS AND SYSTEMS FOR MODULATING HEPATIC GABA PRODUCTION OR RELEASE TO ALTER FOOD INTAKE IN MONOGASTRIC SPECIES ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2021-04-01 WO claimed
WO-2018189484-A1 MATRIX FOR SPECIFIC DETECTION OF ALKALOIDS BY MALDI-TOF MASS SPECTROMETRY Université d'Angers (FR) 2018-10-18 WO claimed
CN-108445131-A The detection method of main component in a kind of edible areca-nut 湖南中医药大学 2018-08-24 CN claimed
US-9101662-B2 Compositions with modulating agents FOAMIX PHARMACEUTICALS LTD. (IL) 2015-08-11 US claimed
EP-2734514-B1 USE OF A THIOPHENE COMPOUND AS A MATRIX IN THE SPECIFIC DETECTION, IDENTIFICATION AND/OR QUANTIFICATION OF ALKALOIDS BY MALDI-TOF MASS SPECTROMETRY UNIV ANGERS (FR) 2015-07-08 EP claimed
EP-0789567-A4 A METHOD FOR TREATING VASCULAR HEADACHES GEN HOSPITAL CORP (US) 1999-01-13 EP claimed
WO-1998019674-A2 A METHOD FOR TREATING TENSION-TYPE HEADACHE HEAD EXPLORER APS (DK) 1998-05-14 WO claimed
WO-1997049403-A1 USE OF NIPECOTIC ACID OR GUVACINE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF POSTISCHEMIC NEURODEGENERATIVE DISORDERS UNIVERSITY COLLEGE DUBLIN (US) 1997-12-31 WO claimed
WO-1997043902-A1 USE OF GABA UPTAKE INHIBITORS AS ANTI-TUSSIVE AGENTS SMITHKLINE BEECHAM CORPORATION (US) 1997-11-27 WO claimed
EP-0789567-A1 A METHOD FOR TREATING VASCULAR HEADACHES THE GENERAL HOSPITAL CORPORATION (US) 1997-08-20 EP claimed
WO-1996015782-A1 A METHOD FOR TREATING VASCULAR HEADACHES THE GENERAL HOSPITAL CORPORATION (US) 1996-05-30 WO claimed
EP-0231996-B1 NOVEL AMINO ACID DERIVATIVES NOVO NORDISK A/S (DK) 1993-10-06 EP claimed
EP-0537993-A1 Nicotinic activity of a series of arecolones and isoarecolones ELI LILLY AND COMPANY (US) 1993-04-21 EP claimed
US-5010090-A N-(butenyl substituted) azaheterocyclic carboxylic acids NOVO NORDISK A/S. (DK) 1991-04-23 US claimed
US-4931450-A Amino acid derivatives NOVO INDUSTRI A/S (DK) 1990-06-05 US claimed